#United States #San Diego #Illumina #DNA Sequencing #AGBT

Upcoming Illumina Investor Webcast

Illumina, Inc., a leading name in the field of genome technology, has made an exciting announcement regarding its participation in the upcoming Advances in Genome Biology and Technology (AGBT) conference. The company will host a live webcast for investors, analysts, and interested stakeholders to engage with key executives and gain insights into their innovations and company performance.

Event Details

The investor session is scheduled for February 25, 2025, commencing at 8:00 AM Pacific Time (11:00 AM Eastern Time). This session will feature a distinguished panel comprising Jacob Thaysen (Chief Executive Officer), Ankur Dhingra (Chief Financial Officer), and Steve Barnard (Chief Technology Officer). The event is set to foster dialogue surrounding Illumina's recent advancements in technology and strategies aimed at enhancing healthcare through genome analysis.

For those interested in attending the webcast, it can be accessed through the Investor Info section of Illumina's official website. It is advisable for participants to join the session at least ten minutes early to ensure a smooth connection and experience.

Replay Availability

If you're unable to attend the live session, don't worry! A replay will be available on Illumina’s website for at least 30 days following the original broadcast. This allows stakeholders to revisit the insightful discussions and updates presented during the session at their convenience.

About Illumina

Illumina strives to improve global health by harnessing the capabilities of the genome. As a pioneer and global leader in DNA sequencing and array-based technologies, the company is known for its commitment to innovation. Illumina focuses on providing solutions that span diverse sectors including life sciences, oncology, reproductive health, and agriculture.

Illumina's products are instrumental in various applications that help researchers and clinicians unlock critical information from genomic data. By continuously pushing the boundaries of technology, Illumina empowers advancements in clinical research, academic studies, and other emerging markets.

For more information about Illumina and their groundbreaking work, visit their official website. They are also active on social media platforms such as Twitter, Facebook, LinkedIn, Instagram, TikTok, and YouTube, where they share updates about their initiatives and achievements.

With the upcoming investor webcast, Illumina opens the door for greater transparency and communication with its stakeholders, reinforcing its position as a trusted leader in genomic healthcare.

For further inquiries, please contact:
Salli Schwartz
Investor Relations
+1 858-291-6421
[email protected]

Bonny Fowler
Media Relations
+1 740-641-5579
[email protected]